Paper23756608
Adjunctive lisdexamfetamine dimesylate therapy in adult outpatients with predominant negative symptoms of schizophrenia: open-label and randomized-withdrawal phases.
Lasser RA and 7 others. Neuropsychopharmacology, 2013. Cited by 41 papers, by iCite.
Cite this record
ConductScience Library. Adjunctive lisdexamfetamine dimesylate therapy in adult outpatients with predominant negative symptoms of schizophrenia: open-label and randomized-withdrawal phases. Papers, record 23756608. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23756608
- Disease
- schizophrenia345 drugs
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Dextroamphetamine | Major topic |
| Dopamine Agonists | Major topic |
| Schizophrenia | Major topic |
| Adult | |
| Antipsychotic Agents | |
| Double-Blind Method | |
| Drug Administration Schedule | |
| Drug Therapy, Combination | |
| Female | |
| Humans | |
| Lisdexamfetamine Dimesylate | |
| Male | |
| Outpatients |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT00922272 | Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative Symptoms | Results |
Source ClinicalTrials.gov
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 2884687 | Provocative tests with psychostimulant drugs in schizophrenia. | Psychopharmacology (Berl) | 1987 | https://conductscience.org/library/papers/2884687 | PubMed |
| 2 | 2278986 | A depression rating scale for schizophrenics. | Schizophr Res | 1990 | https://conductscience.org/library/papers/2278986 | PubMed |
| 3 | 17349856 | Neurobiology of dopamine in schizophrenia. | Int Rev Neurobiol | 2007 | https://conductscience.org/library/papers/17349856 | PubMed |
| 4 | 17244172 | Pharmacological treatment of negative symptoms of schizophrenia: therapeutic opportunity or cul-de-sac? | Acta Psychiatr Scand | 2007 | https://conductscience.org/library/papers/17244172 | PubMed |
| 5 | 17629443 | Psychometric evaluation of the Amphetamine Cessation Symptom Assessment. | J Subst Abuse Treat | 2008 | https://conductscience.org/library/papers/17629443 | PubMed |
| 6 | 17201860 | Negative symptoms of schizophrenia: a problem that will not go away. | Acta Psychiatr Scand | 2007 | https://conductscience.org/library/papers/17201860 | PubMed |
| 7 | 12832232 | Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials. | Am J Psychiatry | 2003 | https://conductscience.org/library/papers/12832232 | PubMed |
| 8 | 2062986 | Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats. | Psychopharmacology (Berl) | 1991 | https://conductscience.org/library/papers/2062986 | PubMed |
| 9 | 3616518 | The positive and negative syndrome scale (PANSS) for schizophrenia. | Schizophr Bull | 1987 | https://conductscience.org/library/papers/3616518 | PubMed |
| 10 | 16198197 | Mechanism of action of antipsychotic drugs: from dopamine D(2) receptor antagonism to glutamate NMDA facilitation. | Clin Ther | 2005 | https://conductscience.org/library/papers/16198197 | PubMed |
| 11 | 10394474 | Increased dopamine transmission in schizophrenia: relationship to illness phases. | Biol Psychiatry | 1999 | https://conductscience.org/library/papers/10394474 | PubMed |
| 12 | 2574607 | A rating scale for drug-induced akathisia. | Br J Psychiatry | 1989 | https://conductscience.org/library/papers/2574607 | PubMed |
| 13 | 18644851 | Negative symptoms in schizophrenia: avolition and Occam's razor. | Schizophr Bull | 2010 | https://conductscience.org/library/papers/18644851 | PubMed |
| 14 | 9448657 | The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials. | J Clin Psychiatry | 1997 | https://conductscience.org/library/papers/9448657 | PubMed |
| 15 | 2861718 | Differential response to amphetamine in schizophrenia. | Acta Psychiatr Scand | 1985 | https://conductscience.org/library/papers/2861718 | PubMed |
| 16 | 15339823 | Stimulant psychosis: systematic review. | Br J Psychiatry | 2004 | https://conductscience.org/library/papers/15339823 | PubMed |
| 17 | 6711703 | Treatment of negative schizophrenia with d-amphetamine. | Am J Psychiatry | 1984 | https://conductscience.org/library/papers/6711703 | PubMed |
| 18 | 15741466 | Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. | Am J Psychiatry | 2005 | https://conductscience.org/library/papers/15741466 | PubMed |
| 19 | 19012818 | Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. | J Clin Psychiatry | 2008 | https://conductscience.org/library/papers/19012818 | PubMed |
| 20 | 6817367 | Partial improvement in negative schizophrenic symptoms after amphetamine. | Psychopharmacology (Berl) | 1982 | https://conductscience.org/library/papers/6817367 | PubMed |
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 41 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40595332 | Long term safety of ADHD medication in patients with schizophrenia spectrum disorders. | Mol Psychiatry | 2025 | https://conductscience.org/library/papers/40595332 | PubMed |
| 40227151 | Pharmacologic Augmentation of Computerized Auditory Training in Chronic Psychosis: Preliminary Findings From a Single-Site, Double-Blind Study. | Schizophr Bull | 2025 | https://conductscience.org/library/papers/40227151 | PubMed |
| 39337126 | Pharmacological Treatments of Negative Symptoms in Schizophrenia-An Update. | J Clin Med | 2024 | https://conductscience.org/library/papers/39337126 | PubMed |
| 39205914 | Adjunctive methylphenidate extended release in patients with schizophrenia: Protocol of a single-centre fixed dose cross-over open-label trial to improve functional and cognitive outcomes. | Contemp Clin Trials Commun | 2024 | https://conductscience.org/library/papers/39205914 | PubMed |
| 38842809 | Cognitive Impairments in Drug-Naive Patients With First-Episode Negative Symptom-Dominant Psychosis. | JAMA Netw Open | 2024 | https://conductscience.org/library/papers/38842809 | PubMed |
| 37358825 | Social Psychopharmacology: Novel Approaches to Treat Deficits in Social Motivation in Schizophrenia. | Schizophr Bull | 2023 | https://conductscience.org/library/papers/37358825 | PubMed |
| 35884767 | BPC 157, L-NAME, L-Arginine, NO-Relation, in the Suited Rat Ketamine Models Resembling "Negative-Like" Symptoms of Schizophrenia. | Biomedicines | 2022 | https://conductscience.org/library/papers/35884767 | PubMed |
| 34227057 | Developments in Biological Mechanisms and Treatments for Negative Symptoms and Cognitive Dysfunction of Schizophrenia. | Neurosci Bull | 2021 | https://conductscience.org/library/papers/34227057 | PubMed |
| 33603883 | Current perspectives in treating negative symptoms of schizophrenia: A narrative review (Review). | Exp Ther Med | 2021 | https://conductscience.org/library/papers/33603883 | PubMed |
| 32318751 | Amphetamine improves rat 5-choice continuous performance test (5C-CPT) irrespective of concurrent low-dose haloperidol treatment. | Psychopharmacology (Berl) | 2020 | https://conductscience.org/library/papers/32318751 | PubMed |
| 31445502 | Lessons learned by giving amphetamine to antipsychotic-medicated schizophrenia patients. | Neuropsychopharmacology | 2019 | https://conductscience.org/library/papers/31445502 | PubMed |
| 29687627 | Anhedonia in depression and schizophrenia: A transdiagnostic challenge. | CNS Neurosci Ther | 2018 | https://conductscience.org/library/papers/29687627 | PubMed |
| 29627173 | Room to move: Plasticity in early auditory information processing and auditory learning in schizophrenia revealed by acute pharmacological challenge. | Schizophr Res | 2018 | https://conductscience.org/library/papers/29627173 | PubMed |
| 28243210 | The Obesity-Impulsivity Axis: Potential Metabolic Interventions in Chronic Psychiatric Patients. | Front Psychiatry | 2017 | https://conductscience.org/library/papers/28243210 | PubMed |
| 27798224 | Amphetamine Enhances Gains in Auditory Discrimination Training in Adult Schizophrenia Patients. | Schizophr Bull | 2017 | https://conductscience.org/library/papers/27798224 | PubMed |
| 27376016 | Treating Negative Symptoms in Schizophrenia: an Update. | Curr Treat Options Psychiatry | 2016 | https://conductscience.org/library/papers/27376016 | PubMed |
| 27372312 | Antipsychotic Drug-Induced Somnolence: Incidence, Mechanisms, and Management. | CNS Drugs | 2016 | https://conductscience.org/library/papers/27372312 | PubMed |
| 27143885 | Novel pharmacologic treatment in acute binge eating disorder - role of lisdexamfetamine. | Neuropsychiatr Dis Treat | 2016 | https://conductscience.org/library/papers/27143885 | PubMed |
| 26694811 | Effects of lisdexamfetamine and s-citalopram, alone and in combination, on effort-related choice behavior in the rat. | Psychopharmacology (Berl) | 2016 | https://conductscience.org/library/papers/26694811 | PubMed |
| 25312027 | Wake-promoting pharmacotherapy for psychiatric disorders. | Curr Psychiatry Rep | 2014 | https://conductscience.org/library/papers/25312027 | PubMed |
Drugs1
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets |
|---|---|---|---|---|
| LISDEXAMFETAMINE DIMESYLATE | CHEMBL1201178 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL1201178 |
Source ChEMBL
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Genes
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23756608
GET https://conductscience.org/api/papers/v1/23756608/references?page=2